Pennsylvania Rep. Chris Deluzio joined Massachusetts Sen. Edward Markey to introduce the All Aboard Act, a bill that would ...
When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
In fact, from Merck's $1.3 billion deal to GSK's $850 million investment, the "gold content" of Chinese companies' self-developed TCE bispecific antibodies has already been well proven. The new moves ...
Invikafusp alfa has gained FDA fast track designation for treating TMB-H metastatic colorectal cancer. Invikafusp alfa ...
A recent study, published in the journal Chemosphere and taken up widely by news outlets, shows that many black plastic household products contain brominated flame retardants, which are possibly ...
Phase 1 data indicate invikafusp alfa's potential as a precision cancer immunotherapeutic in solid tumors that have ...
A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...